Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > NanoGuardian’s On-Dose NanoEncryption Brand Protection Technology Presented at AAPS: NanoEncryption technology incorporates sophisticated, nanoscale, authentication and tracing features directly on medications without affecting dissolution or stability

Abstract:
NanoGuardian™, a division of NanoInk®, Inc. that delivers on-dose brand protection solutions to the pharmaceutical industry to fight counterfeiting and illegal diversion, announced today that it will give a poster presentation at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exhibition, which is being held on October 14 - 18, at McCormick Place in Chicago. The abstract, "Can Nanofabrication be used to Combat Counterfeit Medicines by Applying On-dose Authentication Features without Disrupting the Integrity of the Medicine?" will be presented on Monday, October 15, from 1:30 to 4:30 p.m. in Hall F by Bjoern Rosner, director of research and development, brand protection for NanoGuardian.

NanoGuardian’s On-Dose NanoEncryption Brand Protection Technology Presented at AAPS: NanoEncryption technology incorporates sophisticated, nanoscale, authentication and tracing features directly on medications without affecting dissolution or stability

Skokie, IL | Posted on October 11th, 2012

"Counterfeit medicines have become such a problem that pharmaceutical manufacturers are evaluating how to best ensure the integrity of their medicines for patients early in the drug development process," said Dean Hart, chief commercial officer of NanoGuardian. "The AAPS poster presentation will demonstrate that NanoGuardian's NanoEncryption technology can be used to incorporate highly sophisticated nanoscale, authentication, and tracing features directly on film-coated tablets, gelatin capsules, and vial caps without affecting the dissolution or stability of the medication - important considerations in the development and commercialization of a new medication."

NanoGuardian's NanoEncryption technology is the only on-dose, multi-layered, brand protection solution that enables pharmaceutical manufacturers to authenticate and trace every single dose, from plant to patient. NanoGuardian's Closed-Loop Protection Program combines the on-dose authentication and tracing benefits of NanoEncryption technology with a proactive supply chain auditing program to identify counterfeit or illegally diverted pharmaceuticals entering the global supply chain as early as possible.

NanoGuardian fights both counterfeiting and illegal diversion with a single technology that can be used to protect capsules, tablets, vial caps, and single-use syringes providing a layered security of overt, covert, and forensic features. The overt and covert security features allow dose-level authentication at any point in the supply chain, while the forensic and nano-scale NanoCodes provide comprehensive tracing information on each and every dose. NanoGuardian's technology provides a strong benefit over other on-dose technologies given that NanoGuardian's security features are implemented with no additional material or chemicals being added to the medication.

As evidence of the rapidly growing problem of counterfeit pharmaceuticals, a recent report from the U.S. Customs and Border Protection and the U.S. Immigration and Customs Enforcement noted that the domestic value of counterfeit pharmaceutical seizures in fiscal year 2011 rose by more than $11 million, an increase of almost 200 percent. The implications for victims of counterfeit drugs are extremely serious, often resulting in unexpected side effects, severe allergic reactions and even death.

AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to health. It offers timely scientific programs, ongoing education, opportunities for networking, and professional development. More information is available at: www.aaps.org.

####

About NanoInk
NanoGuardian™, a division of NanoInk®, Inc., focuses exclusively on delivering brand protection solutions to fight illegal diversion and counterfeiting. Anchored by NanoInk’s novel NanoEncryption™ technology, NanoGuardian enables manufacturers to authenticate and trace the integrity of their products across the supply chain. More information about NanoGuardian is available at www.nanoguardian.net.

NanoInk, NanoGuardian, NanoEncryption and the NanoGuardian logo are trademarks or registered trademarks of NanoInk, Inc.

For more information, please click here

Contacts:
Joshua Taustein
Associate
Dresner Corporate Services
20 N. Clark St. Suite 3550
Chicago, IL 60602
Direct: (312)780-7219
Mobile: (847)308-5168
www.dresnerpr.com

Copyright © NanoInk, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Law enforcement/Anti-Counterfeiting/Security/Loss prevention

Russian scientists develop long-range secure quantum communication system April 13th, 2016

New laser technique promises super-fast and super-secure quantum cryptography April 7th, 2016

Record-breaking steel could be used for body armor, shields for satellites April 7th, 2016

Protected Majorana states for quantum information March 12th, 2016

Announcements

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Events/Classes

Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016

Introducing the RE標ORK Bio-inspired Robotics Summit in Berlin April 27th, 2016

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Team builds first quantum cascade laser on silicon: Eliminates the need for an external light source for mid-infrared silicon photonic devices or photonic circuits April 21st, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic